Patient-friendly summary
If you read nothing else
Bottom line
Understanding myofascial pain syndromes can help identify effective treatments.
Moderate evidenceNot everyone agrees
Myofascial pain syndromes are often under-diagnosed or misdiagnosed due to incomplete knowledge and lack of internationally validated diagnostic criteria.
You're not alone
“Myofascial pain syndromes are common and when properly identified, can be effectively treated with appropriate therapeutic interventions.”
Published
Evidence hierarchy
Full research — for clinicians and curious readers
Study Summary
Background
Myofascial pain syndromes (MPS) originating from trigger points are among the most common pain conditions in the general population, yet they remain frequently under-diagnosed or misdiagnosed. This comprehensive review addresses the critical gap in understanding these conditions, which affects an estimated 37% of middle-aged men and 65% of women, rising to 85% in elderly individuals. The lack of internationally validated diagnostic criteria and confusion with other musculoskeletal disorders leads to inappropriate or delayed treatment, causing significant suffering and disability.
What They Did
The authors conducted a thorough review of published literature on myofascial pain syndromes, examining diagnostic approaches, pathophysiology, and treatment options. They analyzed various diagnostic criteria, particularly those developed by Simons and colleagues, and reviewed the reliability of physical examination techniques for identifying trigger points. The review examined sensory evaluation methods, including pain threshold measurements, and discussed various instrumental tests including electromyography, ultrasound, and thermography. They also explored the role of trigger points in other pain conditions like headache, fibromyalgia, and visceral pain.
What They Found
The most reliable diagnostic features for MPS include identification of taut bands within muscles, reproduction of spontaneous pain by pressure on tender points within these bands, and the characteristic pattern of referred pain to target areas. Studies show that trigger points cause regional tissue hyperalgesia affecting not only muscle but also overlying skin and subcutaneous tissue, unlike the diffuse hyperalgesia seen in fibromyalgia. The authors found that trigger points can act as peripheral pain generators that worsen symptoms of other conditions through central sensitization mechanisms. Regarding treatment, the authors described trigger point injection with local anesthetic as often more effective than stretching techniques alone, with dry needling showing comparable effectiveness.
Secondary trigger points can develop in muscles affected by visceral or other deep somatic pain sources.
What This Means
This review provides clinicians with evidence-based guidance for diagnosing and treating myofascial pain syndromes. The finding that trigger points can exacerbate other pain conditions highlights the importance of systematic trigger point assessment in patients with headache, fibromyalgia, or chronic pain. For patients, this means that proper identification and treatment of trigger points can provide effective pain relief and prevent progression from latent to active trigger points. The review emphasizes that successful MPS treatment requires both trigger point release and correction of perpetuating factors like postural abnormalities or repetitive activities.
The high prevalence of these conditions in aging populations makes this knowledge increasingly important for healthcare providers.
- Prevalence in Elderly
- 85%
- Prevalence in Women
- 65%
- Prevalence in Men
- 37%
- Trigger Point-Acupuncture Correlation
- 71%
Key Findings
| Finding | Detail | Impact |
|---|---|---|
| MPS prevalence reaches 85% in elderly population over 65 years | Dramatically higher than 37% in middle-aged men and 65% in middle-aged women, indicating age-related increase | High |
| Trigger point injection with anesthetic often outperformed stretching alone | Reported as more effective than stretching techniques alone and about as effective as dry needling for trigger point inactivation | High |
| Regional hyperalgesia pattern distinguishes MPS from fibromyalgia | Hyperalgesia confined to trigger and target areas only, versus diffuse hyperalgesia in fibromyalgia patients | High |
| Trigger points can activate symptoms in other pain conditions | TrP treatment reduced migraine attacks and fibromyalgia symptoms through central sensitization mechanisms | High |
| Taut band identification most reliable diagnostic feature | Combined with tender point palpation and pain reproduction provides best clinical diagnostic accuracy | Medium |
| Secondary trigger points develop from visceral or deep somatic pain | Through neurogenic inflammation and central sensitization within same neurological segments | Medium |
Strengths
- Comprehensive review of diagnostic criteria and pathophysiology
- Systematic evaluation of treatment options with clinical evidence
- Clear distinction between MPS and other pain syndromes
- Integration of basic science and clinical practice
Limitations
- Lack of internationally validated diagnostic criteria
- Limited high-quality randomized controlled trials
- Variable reliability of physical examination techniques
- Need for more research on therapeutic ultrasound
Key Takeaways for Patients
What This Means for You
Trigger points are very common, affecting most adults especially as they age, but are often overlooked by healthcare providers
The muscle knots can cause pain that spreads to distant areas of your body, not just where the knot is located
Effective treatments exist including injections and stretching, with most people experiencing significant pain relief
Trigger points can make other conditions like headaches and fibromyalgia worse, so treating them may help multiple problems
Long-term success requires fixing the underlying causes like poor posture or repetitive activities that created the trigger points
Read the Full Paper
Access the complete peer-reviewed study from Best Practice & Research Clinical Rheumatology